VIROCELL Trademark

Trademark Overview


On Tuesday, July 25, 2023, a trademark application was filed for VIROCELL with the United States Patent and Trademark Office. The USPTO has given the VIROCELL trademark a serial number of 98100387. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, September 17, 2024. This trademark is owned by ViroCell Biologics Ltd. The VIROCELL trademark is filed in the Pharmaceutical Products, Treatment & Processing of Materials Services, and Computer & Software Services & Scientific Services categories with the following description:

Manufacturing services for others in the field of pharmaceuticals, biopharmaceuticals, health care products and medical products; manufacture of pharmaceuticals and biopharmaceuticals to order and/or specification of others; contract manufacturing of pharmaceuticals and gene therapy reagents

Pharmaceutical preparations, biological preparations, and gene therapy pharmaceutical and biological products for medical or pharmaceutical purposes, namely, gene therapies, viral vectors, DNA plasmids, and nucleic-acid delivery products all for use in the treatment of genetic diseases and disorders

Product development for others relating to pharmaceuticals, biopharmaceuticals, health care products and medical products; scientific and technological consulting services in the pharmaceutical industry, and research and design relating thereto; pharmaceutical and biopharmaceutical drug development services; pharmaceutical and biopharmaceutical research and development
virocell

General Information


Serial Number98100387
Word MarkVIROCELL
Filing DateTuesday, July 25, 2023
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, September 17, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 17, 2024

Trademark Statements


Goods and ServicesManufacturing services for others in the field of pharmaceuticals, biopharmaceuticals, health care products and medical products; manufacture of pharmaceuticals and biopharmaceuticals to order and/or specification of others; contract manufacturing of pharmaceuticals and gene therapy reagents
Goods and ServicesPharmaceutical preparations, biological preparations, and gene therapy pharmaceutical and biological products for medical or pharmaceutical purposes, namely, gene therapies, viral vectors, DNA plasmids, and nucleic-acid delivery products all for use in the treatment of genetic diseases and disorders
Goods and ServicesProduct development for others relating to pharmaceuticals, biopharmaceuticals, health care products and medical products; scientific and technological consulting services in the pharmaceutical industry, and research and design relating thereto; pharmaceutical and biopharmaceutical drug development services; pharmaceutical and biopharmaceutical research and development

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, August 24, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateTuesday, August 6, 2024
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, August 6, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameViroCell Biologics Ltd
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressLondon WC1X8SL
GB

Party NameViroCell Biologics Ltd
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressLondon WC1X8SL
GB

Trademark Events


Event DateEvent Description
Thursday, August 24, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 6, 2024ASSIGNED TO EXAMINER
Tuesday, February 6, 2024NON-FINAL ACTION WRITTEN
Tuesday, February 6, 2024NON-FINAL ACTION E-MAILED
Tuesday, February 6, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, August 6, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 12, 2024EXAMINERS AMENDMENT -WRITTEN
Monday, August 12, 2024EXAMINER'S AMENDMENT ENTERED
Monday, August 12, 2024EXAMINERS AMENDMENT E-MAILED
Monday, May 6, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Monday, May 6, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Tuesday, August 6, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, August 7, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 12, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, August 12, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 28, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 17, 2024PUBLISHED FOR OPPOSITION
Tuesday, September 17, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED